➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: September 18, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Ezatiostat

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Ezatiostat?

Ezatiostat is an investigational drug.

There have been 7 clinical trials for Ezatiostat. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2008.

The most common disease conditions in clinical trials are Preleukemia, Myelodysplastic Syndromes, and Syndrome. The leading clinical trial sponsors are Telik and [disabled in preview].

Recent Clinical Trials for Ezatiostat
Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic SyndromeTelikPhase 2
Study of (Telintra®) in Non-Del(5q) Myelodysplastic SyndromeTelikPhase 2
Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)TelikPhase 1

See all Ezatiostat clinical trials

Clinical Trial Summary for Ezatiostat

Top disease conditions for Ezatiostat
Top clinical trial sponsors for Ezatiostat

See all Ezatiostat clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.